Clinical trial
A Randomized, Double-blind, Very Low Dose Parallel-controlled, Prospective, Multi-center Trial Evaluating the Improvement of Nutritional Status and Frailty With Silkworm Pupa Tablets After Radical Resection of Gastrointestinal Malignancies
NCT06551675 is registered in ClinicalTrials.gov with Xiaosun Liu, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Very Low Dose Parallel-controlled, Prospective, Multi-center Trial Evaluating the Improvement of Nutritional Status and Frailty With Silkworm Pupa Tablets After Radical Resection of Gastrointestinal Malignancies
- Lead sponsor
- Xiaosun Liu, MD
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 14, 2024
- Completion date
- October 26, 2025
- Enrollment
- 120 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
frailty syndrome, gastrointestinal cancer, nutritional deficiency